C Goddard

4.7k total citations · 1 hit paper
17 papers, 846 citations indexed

About

C Goddard is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, C Goddard has authored 17 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in C Goddard's work include Synthesis and Characterization of Heterocyclic Compounds (3 papers), Synthesis and biological activity (3 papers) and Fungal Plant Pathogen Control (2 papers). C Goddard is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (3 papers), Synthesis and biological activity (3 papers) and Fungal Plant Pathogen Control (2 papers). C Goddard collaborates with scholars based in United States, United Kingdom and Malaysia. C Goddard's co-authors include Richard Kahn, Marianna M. Newkirk, J A Slack, M. F. G. STEVENS, Ronald L. Felsted, R. L. Stone, Neil W. Gibson, Daniel Chubb, J A Hickman and Constance J. Glover and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Biochemical Journal.

In The Last Decade

C Goddard

17 papers receiving 811 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.

1987 335 citations M. F. G. STEVENS, J A Hickman et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Goddard United States	11	480	195	184	133	123	17	846
Ota Fuchs Czechia	18	569 1.2×	164 0.8×	211 1.1×	111 0.8×	46 0.4×	67	1.0k
María Fraile Spain	16	419 0.9×	191 1.0×	231 1.3×	142 1.1×	81 0.7×	40	1.1k
M Jacrot France	15	376 0.8×	378 1.9×	106 0.6×	109 0.8×	107 0.9×	31	796
Clifton Stephens United States	16	515 1.1×	256 1.3×	94 0.5×	100 0.8×	115 0.9×	23	966
Heriberto Bruzzoni‐Giovanelli France	15	570 1.2×	281 1.4×	120 0.7×	64 0.5×	80 0.7×	23	932
Elizabeth Cohen–Jonathan France	13	554 1.2×	302 1.5×	145 0.8×	175 1.3×	101 0.8×	16	1.0k
Kateřina Kuželová Czechia	19	511 1.1×	155 0.8×	131 0.7×	172 1.3×	84 0.7×	59	972
German B. Villanueva United States	18	307 0.6×	67 0.3×	158 0.9×	89 0.7×	249 2.0×	40	869
Phyllis Wachsberger United States	18	683 1.4×	224 1.1×	146 0.8×	157 1.2×	96 0.8×	41	1.1k
Günter Krause Germany	17	793 1.7×	152 0.8×	322 1.8×	55 0.4×	223 1.8×	45	1.3k

Countries citing papers authored by C Goddard

Since Specialization

Citations

This map shows the geographic impact of C Goddard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Goddard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Goddard more than expected).

Fields of papers citing papers by C Goddard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Goddard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Goddard. The network helps show where C Goddard may publish in the future.

Co-authorship network of co-authors of C Goddard

This figure shows the co-authorship network connecting the top 25 collaborators of C Goddard. A scholar is included among the top collaborators of C Goddard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Goddard. C Goddard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Goddard, C, et al.. (1996). Reporter Assays in the High Throughput Screening Laboratory: A Rapid and Robust First Look?. SLAS DISCOVERY. 1(3). 115–118. 14 indexed citations

Dow, Robert L., Bruce M. Bechle, Thomas T. Chou, C Goddard, & Eric R. Larson. (1995). Selective inhibition of the tyrosine kinase pp60src by analogs of 5,10-dihydropyrimido[4,5-b]quinolin-4(1H)-one. Bioorganic & Medicinal Chemistry Letters. 5(9). 1007–1010. 28 indexed citations

Wring, Stephen A., et al.. (1994). A sensitive radioimmunoassay, combined with solid-phase extraction, for the sub-nanogram per ml determination of ondansetron in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 12(3). 361–371. 24 indexed citations

Dow, Robert L., Thomas T. Chou, Bruce M. Bechle, C Goddard, & Eric R. Larson. (1994). Identification of Tricyclic Analogs Related to Ellagic Acid as Potent/Selective Tyrosine Protein Kinase Inhibitors. Journal of Medicinal Chemistry. 37(14). 2224–2231. 36 indexed citations

Wring, Stephen A., et al.. (1994). Radioimmunoassay for the determination of alosetron in human urine and saliva. The Analyst. 119(11). 2395–2395. 1 indexed citations

Dow, Robert L., Thomas T. Chou, Bruce M. Bechle, C Goddard, & Eric R. Larson. (1994). ChemInform Abstract: Identification of Tricyclic Analogues Related to Ellagic Acid as Potent/Selective Tyrosine Protein Kinase Inhibitors.. ChemInform. 25(48). 3 indexed citations

Dijke, Peter ten, Kenneth K. Iwata, C Goddard, et al.. (1990). Recombinant Transforming Growth Factor Type β3: Biological Activities and Receptor-Binding Properties in Isolated Bone Cells. Molecular and Cellular Biology. 10(9). 4473–4479. 89 indexed citations

Goddard, C, Angelo Aquino, Robert I. Glazer, & Ronald L. Felsted. (1989). Chemical characterization of p17^gag from human immunodeficiency virus as an N‐terminally myristoylated protein. European Journal of Biochemistry. 182(2). 323–326. 10 indexed citations

Goddard, C, Susan T. Arnold, & Ronald L. Felsted. (1989). High affinity binding of an N-terminal myristoylated p60 peptide. Journal of Biological Chemistry. 264(26). 15173–15176. 32 indexed citations

10.

Glover, Constance J., C Goddard, & Ronald L. Felsted. (1988). N-myristoylation of p60src. Identification of a myristoyl-CoA:glycylpeptide N-myristoyltransferase in rat tissues. Biochemical Journal. 250(2). 485–491. 57 indexed citations

11.

Goddard, C & Ronald L. Felsted. (1988). Identification of N-myristoylated proteins by reverse-phase high performance liquid chromatography of an azlactone derivative of N-myristoylglycine. Biochemical Journal. 253(3). 839–843. 9 indexed citations

12.

Kahn, Richard, C Goddard, & Marianna M. Newkirk. (1988). Chemical and immunological characterization of the 21-kDa ADP-ribosylation factor of adenylate cyclase.. Journal of Biological Chemistry. 263(17). 8282–8287. 144 indexed citations

13.

STEVENS, M. F. G., J A Hickman, Daniel Chubb, et al.. (1987). Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.. PubMed. 47(22). 5846–52. 335 indexed citations breakdown →

14.

Goddard, C, et al.. (1986). An iodine-125 radioimmunoassay for the direct detection of benzodiazepines in blood and urine. The Analyst. 111(5). 525–525. 10 indexed citations

15.

Slack, J A & C Goddard. (1985). Antitumour imidazotetrazines. Journal of Chromatography B Biomedical Sciences and Applications. 337(1). 178–181. 12 indexed citations

16.

Goddard, C, J A Slack, & M. F. G. STEVENS. (1985). Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice. British Journal of Cancer. 52(1). 37–41. 3 indexed citations

17.

Newlands, ES, G. Blackledge, J A Slack, et al.. (1985). Phase I clinical trial of mitozolomide.. PubMed. 69(7-8). 801–5. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact